Lee v. Boehringer Ingelheim International GMBH et al
Adam Lee |
Boehringer Ingelheim International GMBH, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Promeco S.A. de C.V., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC, GlaxoSmithKline PLC, Pfizer Inc., Albertsons Companies, Inc., Safeway, Inc. and The Vons Companies, Inc. |
3:2024cv00050 |
January 3, 2024 |
US District Court for the Northern District of California |
Trina L Thompson |
Kandis A Westmore |
Personal Inj. Prod. Liability |
28 U.S.C. ยง 1446 pl Petition for Removal - Product Liability |
Both |
Docket Report
This docket was last retrieved on January 4, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 6 Administrative Motion to Consider Whether Another Party's Material Should Be Sealed filed by Pfizer Inc.. (Attachments: #1 Proposed Order Proposed Order, #2 Exhibit Exh 1 Notice o Removal, #3 Exhibit Exh 2 PPF)(Sheldon, Charles) (Filed on 1/4/2024) |
Filing 5 Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 3/26/2024. Initial Case Management Conference set for 4/2/2024 01:30 PM in Oakland, - To be determined. (mbc, COURT STAFF) (Filed on 1/4/2024) |
Filing 4 Case assigned to Magistrate Judge Kandis A. Westmore. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening.Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 1/18/2024. (as, COURT STAFF) (Filed on 1/4/2024) |
Filing 3 Certificate of Interested Entities by Pfizer Inc. identifying Corporate Parent Safeway, Inc., Corporate Parent Boehringer Ingelheim Pharmaceuticals, Inc., Corporate Parent Boehringer Ingelheim International GMBH, Corporate Parent GlaxoSmithKline LLC, Corporate Parent The Vons Companies, Inc., Corporate Parent Albertsons Companies, Inc., Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline Holdings (Americas) Inc., Corporate Parent Boehringer Ingelheim Promeco S.A. de C.V., Corporate Parent GlaxoSmithKline PLC for Pfizer Inc.. re #1 Notice of Removal, (Sheldon, Charles) (Filed on 1/3/2024) |
Filing 2 Administrative Motion to File Under Seal filed by Pfizer Inc.. (Attachments: #1 Proposed Order, #2 Exhibit Exh 1, #3 Exhibit Exh 2)(Sheldon, Charles) (Filed on 1/3/2024) |
Filing 1 NOTICE OF REMOVAL from Alameda Superior Court. Their case number is 23-CV-026473. (Filing fee $405 receipt number ACANDC-18988628). Filed by Pfizer Inc.. (Attachments: #1 Exhibit Exh A, #2 Exhibit Exh B, #3 Exhibit Exh C-complaint, #4 Exhibit Exh D - PPF, #5 Exhibit Exh E-State Court Docs, #6 Certificate/Proof of Service, #7 Civil Cover Sheet)(Sheldon, Charles) (Filed on 1/3/2024) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.